BROWN BROTHERS HARRIMAN & CO – AbbVie Inc. Transaction History
BROWN BROTHERS HARRIMAN & CO portfolio value:
$12.33M
portfolio value
BROWN BROTHERS HARRIMAN & CO quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.02% | 2.69K shares | -1.32M | $134.21 | 91.92K |
| Q2 2022 | share | Increase | +2.35% | 2.05K shares | -466K | $153.16 | 89.22K |
| Q1 2022 | share | Increase | +6.12% | 5.02K shares | 3.00M | $162.11 | 87.17K |
| Q4 2021 | share | Increase | +20.88% | 14.19K shares | 3.79M | $135.93 | 82.14K |
| Q3 2021 | share | Increase | +2.90% | 1.91K shares | -108K | $106.6 | 67.95K |
| Q2 2021 | share | Decrease | -1.12% | -749 shares | 211K | $110.09 | 66.04K |
| Q1 2021 | share | Increase | +2.69% | 1.74K shares | 259K | $104.49 | 66.79K |
| Q4 2020 | share | Decrease | -10.53% | -7.65K shares | 602K | $102.27 | 65.04K |
| Q3 2020 | share | Increase | +5.25% | 3.62K shares | -414K | $82.47 | 72.69K |
| Q2 2020 | share | Increase | +4.45% | 2.94K shares | 1.74M | $91.35 | 69.06K |
| Q1 2020 | share | Increase | +13.34% | 7.78K shares | -127K | $69.88 | 66.12K |
| Q4 2019 | share | Decrease | -7.04% | -4.41K shares | 413K | $80.14 | 58.33K |
| Q3 2019 | share | Decrease | -5.10% | -3.37K shares | -57K | $67.55 | 62.75K |
| Q2 2019 | share | Decrease | -1.97% | -1.32K shares | -627K | $63.9 | 66.12K |
| Q1 2019 | share | Increase | +6.99% | 4.40K shares | -376K | $69.89 | 67.45K |
| Q4 2018 | share | Decrease | -1.25% | -801 shares | -227K | $78.96 | 63.04K |
| Q3 2018 | share | Increase | +11.59% | 6.63K shares | 738K | $80.16 | 63.85K |
| Q2 2018 | share | Decrease | -5.80% | -3.52K shares | -448K | $77.74 | 57.21K |
| Q1 2018 | share | Decrease | -3.04% | -1.90K shares | -310K | $78.6 | 60.74K |
| Q4 2017 | share | Increase | +5.96% | 3.52K shares | 805K | $79.74 | 62.64K |
| Q3 2017 | share | Decrease | -1.63% | -980 shares | 896K | $72.76 | 59.12K |
| Q2 2017 | share | Decrease | -3.02% | -1.87K shares | 320K | $58.85 | 60.10K |
| Q1 2017 | share | Decrease | -5.73% | -3.76K shares | -79K | $52.36 | 61.97K |
| Q4 2016 | share | Decrease | -0.32% | -212 shares | -43K | $49.8 | 65.74K |
| Q3 2016 | share | Decrease | -3.33% | -2.27K shares | -64K | $49.69 | 65.95K |
| Q2 2016 | share | Decrease | -4.68% | -3.34K shares | 136K | $48.35 | 68.22K |
| Q1 2016 | share | Decrease | -1.69% | -1.23K shares | -225K | $44.19 | 71.57K |